Remove Disease Remove Nurses Remove Production
article thumbnail

What are value-added medicines?

Altus Drug Development

Value-added medicines are drug products and treatments created using known molecules through a process known as drug repositioning. Value-added pharmaceutical products can deliver a wide variety of improvements for patients and healthcare professionals. What type of improvement can value-added medicines deliver?

article thumbnail

2021 AAN highlight impact and breadth of expanding neuroscience portfolio

The Pharma Data

OCREVUS data show its consistent benefit on slowing disease progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS). Data for ENSPRYNG in neuromyelitis optica spectrum disorder (NMOSD) reinforce safety and efficacy, including in patients with concomitant autoimmune diseases (CAIDs). Following U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New England Journal of Medicine Publishes Positive Initial Regeneron Antibody Cocktail Results in Non-hospitalized Patients with COVID-19

The Pharma Data

Regeneron continues to increase in-house production of casirivimab and imdevimab, and the company has partnered with Roche to increase the global supply beginning in 2021. Have chronic kidney disease. Have immunosuppressive disease. cardiovascular disease, OR. sickle cell disease, OR. Have diabetes.

article thumbnail

Diality Closes $12.5 Million of Series B Financing to Support Ongoing Development of a Portable System for Acute and Chronic Hemodialysis

The Pharma Data

To accommodate cost-effective delivery outside of specialty dialysis facilities, hemodialysis machines need to be user friendly for non-specialty nurses, patients, and care partners,” says Osman Khawar , M.D., Disclaimer: The performance characteristics of this product have not been established. .

Nurses 40
article thumbnail

What value-added medicines might bring to society

Altus Drug Development

Value-added medicines are drug products created using already known molecules. Drug reformulations are created by investigating already existing pharmaceutical products. The need for value-added medicines Value-based healthcare aims to rethink, reinvent, and optimize drug products, creating innovative treatment options.

article thumbnail

Moderna’s FDA COVID-19 Vaccine Adcom is Thursday, and Expectations are High

The Pharma Data

ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Food and Drug Administration (FDA) ’ s Vaccines and Related Biological Products Advisory Committee on Thursday, December 17. Yesterday was a historic day as the first person in the U.S.,

Vaccine 52
article thumbnail

INVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility Industry

The Pharma Data

She speaks nationally and internationally on how cancer and autoimmune disease therapies affect reproductive health and fertility, ovarian aging, primary ovarian insufficiency and genetics. Hammond , DNP, CRNP is a board-certified Nurse Practitioner, is IVF Program Director at AIRM. Karen R. Karen R.